Profile of bazedoxifene/conjugated estrogens for the treatment of estrogen deficiency symptoms and osteoporosis in women at risk of fracture
Maurizio Rossini,1 Stefano Lello,2 Ignazio Sblendorio,3 Ombretta Viapiana,1 Elena Fracassi,1 Silvano Adami,1 Davide Gatti11Department of Medicine, Rheumatology Unit, University of Verona, Italy; 2Endocrinological Gynecology, Pathophysiology of Menopause and Osteoporosis, Dermopathic Institute of Imm...
Main Authors: | Rossini M, Lello S, Sblendorio I, Viapiana O, Fracassi E, Adami S, Gatti D |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2013-07-01
|
Series: | Drug Design, Development and Therapy |
Online Access: | http://www.dovepress.com/profile-of-bazedoxifeneconjugated-estrogens-for-the-treatment-of-estro-a13733 |
Similar Items
-
88116 Effect of conjugated estrogens and bazedoxifene on glucose, energy and lipid metabolism in obese postmenopausal women
by: Kara Marlatt, et al.
Published: (2021-03-01) -
Bazedoxifene does not share estrogens effects on IgG sialylation.
by: Priti Gupta, et al.
Published: (2023-01-01) -
Repurposing the selective estrogen receptor modulator bazedoxifene to suppress gastrointestinal cancer growth
by: Pathum Thilakasiri, et al.
Published: (2019-04-01) -
Bazedoxifene, a Selective Estrogen Receptor Modulator, Promotes Functional Recovery in a Spinal Cord Injury Rat Model
by: Yiyoung Kim, et al.
Published: (2021-10-01) -
Mechanisms of estrogen deficiency-induced osteoporosis based on transcriptome and DNA methylation
by: Ziying Xu, et al.
Published: (2022-10-01)